NEW MRD MEDICARE COVERAGE FOR SELECT INDICATIONS /// LEARN MORE NEW MRD MEDICARE COVERAGE FOR SELECT INDICATIONS /// LEARN MORE
ORDER A TEST Log In Contact Us
Back TO events
November 11 — 15, 2025 Boston, MA

Booth #1123
Corporate Workshop
Breakout Session
1 Abstract

AMP 2025

Join Tempus at AMP 2025 as we showcase our latest AI-powered digital pathology applications, designed to help pathologists address tissue scarcity, maximize diagnostic yield, and uncover critical insights.

Schedule a meeting with us
Corporate Workshop
November 12, 2025
Time
11:00-11:50am ET

Location
Room 154, Level 1
Speakers
Nike Beaubier, Senior Vice President, Life Science Pathology (Tempus),
Nirali Patel, Vice President, Molecular Pathology (Tempus)

Innovating Pathology Together: Real-World Applications of Digital Pathology and AI-Driven Algorithms

Learn how Tempus addresses tissue scarcity with both RNA-based and digital pathology algorithms.

Add to calendar

Breakout Session
November 14, 2025
Time
10:15-11:00am ET

Location
253ABC, Level 2
Speakers
Rohan Joshi, MD, PhD, Senior Staff Machine Learning Scientist (Tempus)

Digital whole-slide image analysis to optimize the molecular pre-analytical workflow

Add to calendar

Research Highlights
November 14, 2025
Time
9:15-10:15am ET
Author
Mary Jo Fidler, et al.

Molecular Portrait of Integrin Beta-6 (IB6): Characterization of IB6 Expression and Co- Mutation Patterns From the U.S. Real-world Data Study

This is the first real-world study to explore the association between IB6 expression detected by IHC and RNA sequencing and the co-occurrence of IB6-high status and key NSCLC biomarkers. Results demonstrated a significant association between IB6 expression detected by IHC and RNA sequencing. This study begins to characterize IB6-high vs -low expressors using a novel IHC assay and associated cutoff in patients with mNSCLC to inform future developments of IB6-directed therapies.

Add to calendar

Schedule a meeting with us

We'll be in touch shortly.